Kurt A Gustafson Avista Public Acquisition Corp. Ii (AHPAW) insider trading activity

Kurt A Gustafson is Executive VP, Finance and CFO of Avista Public Acquisition Corp. II. Currently has a direct ownership of 217,492 shares of AHPAW, which is worth approximately $150,069. The most recent transaction as insider was on Apr 01, 2025, when has been sold 11,963 shares (Common Stock) at a price of $2.37 per share, resulting in proceeds of $28,352. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 217K

8.39% 3M change

27.85% 12M change

Total Value Held $150,069

KURT A GUSTAFSON Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 01 2025	SELL Open market or private sale	$28,352 $2.37 p/Share	11,963 Reduced 5.21%	217,492 Common Stock
Apr 01 2025	BUY Exercise of conversion of derivative security	-	23,244 Added 9.2%	229,455 Common Stock
Feb 19 2025	SELL Open market or private sale	$26,625 $3.67 p/Share	7,255 Reduced 3.4%	206,211 Common Stock
Feb 16 2025	BUY Exercise of conversion of derivative security	-	13,541 Added 5.97%	213,466 Common Stock
Jan 21 2025	SELL Open market or private sale	$50,304 $3.24 p/Share	15,526 Reduced 6.8%	212,720 Common Stock
Jan 17 2025	BUY Grant, award, or other acquisition	-	27,585 Added 10.78%	228,246 Common Stock
Dec 09 2024	SELL Open market or private sale	$98,587 $4.13 p/Share	23,871 Reduced 10.63%	200,661 Common Stock
Dec 07 2024	BUY Exercise of conversion of derivative security	-	46,501 Added 17.16%	224,532 Common Stock
Apr 08 2024	SELL Open market or private sale	$36,647 $5.27 p/Share	6,954 Reduced 3.79%	176,697 Common Stock
Apr 07 2024	BUY Exercise of conversion of derivative security	-	13,541 Added 6.87%	183,651 Common Stock
Apr 01 2024	SELL Open market or private sale	$64,695 $5.46 p/Share	11,849 Reduced 6.51%	170,110 Common Stock
Apr 01 2024	BUY Exercise of conversion of derivative security	-	23,254 Added 11.33%	181,959 Common Stock
Dec 07 2023	SELL Payment of exercise price or tax liability	$77,992 $4.85 p/Share	16,081 Reduced 9.2%	158,705 Common Stock
Dec 07 2023	BUY Exercise of conversion of derivative security	-	46,503 Added 21.01%	174,786 Common Stock
Apr 07 2023	BUY Grant, award, or other acquisition	-	40,625 Added 10.8%	335,416 Common Stock
Apr 01 2023	SELL Payment of exercise price or tax liability	$29,594 $3.68 p/Share	8,042 Reduced 2.66%	294,791 Common Stock
Jan 03 2023	BUY Grant, award, or other acquisition	-	139,504 Added 31.54%	302,833 Common Stock
Dec 01 2022	SELL Payment of exercise price or tax liability	$22,555 $3.35 p/Share	6,733 Reduced 3.96%	163,329 Common Stock
Nov 28 2022	BUY Open market or private purchase	$28,100 $2.81 p/Share	10,000 Added 5.55%	170,062 Common Stock
Nov 01 2022	BUY Grant, award, or other acquisition	-	160,062 Added 50.0%	160,062 Common Stock

Also insider at

SPPI

SPECTRUM PHARMACEUTICALS INC Healthcare

EVP & Chief Financial Officer

CDXC

ChromaDex Corp. Healthcare

Director

XNCR

Xencor Inc Healthcare

Director

KAG

Kurt A Gustafson

Executive VP, Finance and CFO

Monrovia, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AHPAW shares.

Notify only if

Value

Insider Trading

Get notified when an Avista Public Acquisition Corp. Ii insider buys or sells AHPAW shares.

Notify only if

Operation

Value

Type

News

Receive news related to Avista Public Acquisition Corp. II

Track Activities on AHPAW

Account